Tirzepatide is a GLP-1 and GIP receptor agonist licensed in the UK for type 2 diabetes mellitus treatment Lightheadedness occurs through reduced fluid intake from gastrointestinal effects, blood pressure lowering from weight loss, or hypoglycaemia when combined with insulin or sulfonylureas Seek immediate medical attention for loss of consciousness, chest pain, severe confusion, or persistent vomiting preventing fluid intake Management includes maintaining adequate hydration (6-8 glasses daily), eating regular small meals, rising gradually from sitting or lying positions, and medication review with your GP Report frequent or concerning lightheadedness to your healthcare team within 24 hours for dose adjustment or investigation of alternative causes Table of Contents Why Mounjaro Can Cause Lightheadedness Mounjaro (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus
Carotid artery ultrasound and echocardiography testing to lower the prevalence of Alzheimers disease
This happens because the tool floors decimal doses to ensure that full doses only are counted
Research indicates that PL has toxic effects on different human cancer cell lines and exhibits antitumor activity in rodents (170)
Frequency of hospitalization after exposure to known drug-drug interactions in a Medicaid population
It also comes as a combination medication called Qsymia, which contains topiramate to aid weight loss
